Rayence Co., Ltd. Share Price

Equities

A228850

KR7228850004

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 03:30:00 21/06/2024 am IST 5-day change 1st Jan Change
8,120 KRW -0.98% Intraday chart for Rayence Co., Ltd. -1.81% -13.16%

Financials

Sales 2024 * 140B 101M 8.44B Sales 2025 * 156B 112M 9.39B Capitalization 128B 92.13M 7.7B
Net income 2024 * 16B 11.54M 964M Net income 2025 * 21B 15.14M 1.26B EV / Sales 2024 * -0.14 x
Net cash position 2024 * 147B 106M 8.88B Net cash position 2025 * 153B 110M 9.21B EV / Sales 2025 * -0.16 x
P/E ratio 2024 *
7.81 x
P/E ratio 2025 *
6.24 x
Employees 222
Yield 2024 *
1.23%
Yield 2025 *
1.23%
Free-Float 29.83%
More Fundamentals * Assessed data
Dynamic Chart
Rayence Co., Ltd. agreed to acquire additional 11.55% stake in Woorien Co., Ltd. from Murex Search No.1 Fund managed by Murex Partners LLC for KRW 12.5 billion. CI
Rayence Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Rayence Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Rayence Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2023 CI
Rayence Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Rayence Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Rayence Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Rayence Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Rayence Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Rayence Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Rayence Launches 3D Inline AXI Detector, MIDAS 2121 CI
Rayence Co., Ltd.(KOSDAQ:A228850) dropped from S&P Global BMI Index CI
Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on May 10, 2018. CI
Rayence Co., Ltd.'s Equity Buyback announced on May 10, 2018, has expired with 449,782 shares, representing 2.8% for KRW 8,709.58 million. CI
Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on May 10, 2018. CI
More news
1 day-0.98%
1 week-1.81%
Current month-0.98%
1 month-3.10%
3 months-9.88%
6 months-13.06%
Current year-13.16%
More quotes
1 week
8 090.00
Extreme 8090
9 060.00
1 month
8 090.00
Extreme 8090
9 060.00
Current year
8 030.00
Extreme 8030
9 430.00
1 year
8 030.00
Extreme 8030
11 570.00
3 years
8 030.00
Extreme 8030
17 350.00
5 years
7 140.00
Extreme 7140
17 350.00
10 years
7 140.00
Extreme 7140
24 800.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 -
Director/Board Member 51 -
Director/Board Member 65 -
Members of the board TitleAgeSince
Director/Board Member 65 -
Director/Board Member 51 -
Chief Executive Officer 50 -
More insiders
Date Price Change Volume
21/24/21 8,120 -0.98% 23,937
20/24/20 8,200 0.00% 10,243
19/24/19 8,200 -0.73% 45,504
18/24/18 8,260 +0.24% 571,661
17/24/17 8,240 -0.36% 7,434

End-of-day quote Korea S.E., June 21, 2024

More quotes
Rayence Co., Ltd. is a Korea-based company mainly engaged in the manufacture of medical and veterinary X-ray detector products. Its products include thin film transistor (TFT) detectors and complementary-metal-oxide-semiconductor (CMOS) detectors. The products' brand name consists of 1012WCA, 17SCC/SGC, 1215CF, 1501CF and 0712CF. The Company also manufactures intra oral (I/O) sensors under the brand name of Ez1.0, Ez1.5, and mammography (mammo) machines under the brand 1724CM, 2434CM. The Company distributes its products to domestic and overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8,120 KRW
Average target price
11,500 KRW
Spread / Average Target
+41.63%
Consensus
  1. Stock Market
  2. Equities
  3. A228850 Stock